Trademark: 97203854
Status Date
Monday, January 8, 2024
Filing Date
Wednesday, January 5, 2022
42 Pharmaceutical research and development of fatty acid-conjugated oligonucleotide compounds; scientific research and product development in the field of fatty acid-conjugated oligonucleotide compounds and drug discovery for peripheral nervous system, muscular, and central nervous system disorders; Pharmaceutical research and development of fatty acid-based drug delivery platforms for use in therapeutic discovery and development for peripheral nervous system, muscular, and central nervous system disorders; Pharmaceutical research and development of fatty acid-based drug delivery platforms for use in the treatment of genetic diseases, none of the foregoing related to otorhinolaryngology or otorhinolaryngological pharmaceuticals
Mar 21, 2024
Teas Response To Suspension Inquiry Received
Jan 8, 2024
Report Completed Suspension Check Case Still Suspended
Dec 12, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Dec 12, 2023
Teas Change Of Correspondence Received
Dec 12, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 12, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 22, 2023
Notification Of Letter Of Suspension E-Mailed
May 22, 2023
Letter Of Suspension E-Mailed
May 22, 2023
Suspension Letter Written
Apr 19, 2023
Teas/Email Correspondence Entered
Apr 18, 2023
Correspondence Received In Law Office
Apr 18, 2023
Teas Response To Office Action Received
Oct 18, 2022
Notification Of Non-Final Action E-Mailed
Oct 18, 2022
Non-Final Action E-Mailed
Oct 18, 2022
Non-Final Action Written
Oct 11, 2022
Assigned To Examiner
Jan 10, 2022
New Application Office Supplied Data Entered
Jan 8, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
